Regeneron Pharmaceuticals Stock Technical Analysis
| REGN Stock | USD 723.47 10.22 1.43% |
As of the 26th of February, Regeneron Pharmaceuticals holds the Variance of 3.26, risk adjusted performance of (0.02), and Coefficient Of Variation of (2,987). Compared to fundamental indicators, the technical analysis model allows you to check existing technical drivers of Regeneron Pharmaceuticals, as well as the relationship between them.
Regeneron Pharmaceuticals Momentum Analysis
Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as Regeneron, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to RegeneronRegeneron |
Regeneron Pharmaceuticals Analyst Consensus
| Target Price | Advice | # of Analysts | |
| 1042.95 | Strong Buy | 25 | Odds |
Most Regeneron analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Regeneron stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Regeneron Pharmaceuticals, talking to its executives and customers, or listening to Regeneron conference calls.
Regeneron Pharmaceuticals technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Regeneron Pharmaceuticals Technical Analysis
The output start index for this execution was twenty with a total number of output elements of fourty-one. The Average True Range was developed by J. Welles Wilder in 1970s. It is one of components of the Welles Wilder Directional Movement indicators. The ATR is a measure of Regeneron Pharmaceuticals volatility. High ATR values indicate high volatility, and low values indicate low volatility.
Regeneron Pharmaceuticals Trend Analysis
Use this graph to draw trend lines for Regeneron Pharmaceuticals. You can use it to identify possible trend reversals for Regeneron Pharmaceuticals as well as other signals and approximate when it will take place. Remember, you need at least two touches of the trend line with actual Regeneron Pharmaceuticals price movement. To start drawing, click on the pencil icon on top-right. To remove the trend, use eraser icon.Regeneron Pharmaceuticals Best Fit Change Line
The following chart estimates an ordinary least squares regression model for Regeneron Pharmaceuticals applied against its price change over selected period. The best fit line has a slop of 1.28 , which may suggest that Regeneron Pharmaceuticals market price will keep on failing further. It has 122 observation points and a regression sum of squares at 62262.58, which is the sum of squared deviations for the predicted Regeneron Pharmaceuticals price change compared to its average price change.About Regeneron Pharmaceuticals Technical Analysis
The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of Regeneron Pharmaceuticals on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of Regeneron Pharmaceuticals based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on Regeneron Pharmaceuticals price pattern first instead of the macroeconomic environment surrounding Regeneron Pharmaceuticals. By analyzing Regeneron Pharmaceuticals's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of Regeneron Pharmaceuticals's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to Regeneron Pharmaceuticals specific price patterns or momentum indicators. Please read more on our technical analysis page.
| 2022 | 2023 | 2024 | 2025 (projected) | Days Sales Outstanding | 159.78 | 157.7 | 159.65 | 167.63 | PTB Ratio | 3.41 | 3.61 | 2.62 | 5.14 |
Regeneron Pharmaceuticals February 26, 2025 Technical Indicators
Most technical analysis of Regeneron help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Regeneron from various momentum indicators to cycle indicators. When you analyze Regeneron charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | (0.02) | |||
| Market Risk Adjusted Performance | 0.139 | |||
| Mean Deviation | 1.41 | |||
| Coefficient Of Variation | (2,987) | |||
| Standard Deviation | 1.81 | |||
| Variance | 3.26 | |||
| Information Ratio | (0.04) | |||
| Jensen Alpha | (0.07) | |||
| Total Risk Alpha | (0.05) | |||
| Treynor Ratio | 0.129 | |||
| Maximum Drawdown | 8.14 | |||
| Value At Risk | (3.61) | |||
| Potential Upside | 2.15 | |||
| Skewness | (0.42) | |||
| Kurtosis | 0.4158 |
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Regeneron Pharmaceuticals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price. To learn how to invest in Regeneron Stock, please use our How to Invest in Regeneron Pharmaceuticals guide.You can also try the Sync Your Broker module to sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors..
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Regeneron Pharmaceuticals. If investors know Regeneron will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Regeneron Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.21) | Earnings Share 37.47 | Revenue Per Share | Quarterly Revenue Growth 0.103 | Return On Assets |
The market value of Regeneron Pharmaceuticals is measured differently than its book value, which is the value of Regeneron that is recorded on the company's balance sheet. Investors also form their own opinion of Regeneron Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Regeneron Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Regeneron Pharmaceuticals' market value can be influenced by many factors that don't directly affect Regeneron Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Regeneron Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Regeneron Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Regeneron Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.